$SNTA Roth Capital Reaffirms Buy On Synta Pharmaceuticals; Sees 844% Upside http://www.smarteranalyst.com/2014/11/06/roth-capital-reaffirms-buy-on-synta-pharmaceuticals-sees-844-upside/